Search Results - "Kamminga, Nadia C W"

Oncological healthcare providers' perspectives on appropriate melanoma survivorship care: a qualitative focus group study by Kamminga, Nadia C W, Wakkee, Marlies, De Bruin, Rianne J, van der Veldt, Astrid A M, Joosse, Arjen, Reeder, Suzan W I, Plaisier, Peter W, Nijsten, Tamar, Lugtenberg, Marjolein

“…The increasing group of melanoma survivors reports multiple unmet needs regarding survivorship care (SSC). To optimise melanoma SSC, it is crucial to take into…”
Get full text

Experiences of resuming life after immunotherapy and associated survivorship care needs: a qualitative study among patients with metastatic melanoma by Kamminga, Nadia C.W., Veldt, Astrid A.M., Joosen, Margot C.W., Joode, Karlijn, Joosse, Arjen, Grünhagen, Dirk J., Nijsten, Tamar E.C., Wakkee, Marlies, Lugtenberg, Marjolein

“…Background Immune checkpoint inhibitors (ICIs) have significantly improved the overall survival of patients with metastatic melanoma. It is unclear how the…”
Get full text

Determining the core content of a digital survivorship care plan for melanoma survivors: a multistakeholder Delphi consensus study by Kamminga, Nadia C W, Wakkee, Marlies, Swart, Inez, Nijsten, Tamar E C, Lugtenberg, Marjolein

“…Increasing melanoma incidence and improved survival emphasize the importance of survivorship care plans (SCPs). We conducted a multistakeholder Delphi study to…”
Get full text

Facilitators and Barriers in the Implementation and Adoption of Patient-Reported Outcomes Measurements in Daily Practice by Huberts, Anouk S., Koppert, Linetta B., Benschop, Joica A.M., Meerstra, Jelle W., van ‘t Spijker, Adriaan, van Lint, Céline, Kamminga, Nadia C.W., den Hollander, Monique S., Peters, Ingrid A., van der Woude, Christien J.

“…At the Erasmus Medical Center, patient-reported outcomes measures (PROMs) are implemented on a hospital-wide scale. However, less than half of the patients and…”
Get full text

From decision to reflection: understanding the experiences and unmet care needs of patients treated with immunotherapy for melanoma in the adjuvant or metastatic setting by Kamminga, Nadia C W, van der Veldt, Astrid A M, Wakkee, Marlies, van den Berge, Fauve R, van der Beek, Lianne A A, Joosen, Margot C W, Joosse, Arjen, de Joode, Karlijn, Nijsten, Tamar E C, Lugtenberg, Marjolein

“…Despite increased use of immune checkpoint inhibitors (ICIs) in patients with advanced melanoma, little is known about patient experiences during this…”
Get full text